This might reflect the insignificant difference of plasma adiponectin or leptin levels among each component group, a finding that is different from previous studies where plasma adiponectin levels decreased as components of MS increased [24,25], with leptin showing the opposite trend [33]. Here, ADIPOQ is linked to myeloid sarcoma.